Postoperative serum CA19-9, YKL-40, CRP and IL-6 in combination with CEA as prognostic markers for recurrence and survival in colorectal cancer

Keyphrases

• C-reactive Protein 100%
• Interleukin-6 100%
• Prognostic Marker 100%
• Colorectal Cancer 100%
• YKL-40 100%
• Carcinoembryonic Antigen 100%
• Serum CA19-9 100%
• Postoperative Carcinoembryonic Antigen 57%
• Overall Survival 42%
• Colorectal Cancer Patients 42%
• Carbohydrate Antigen 19-9 (CA19-9) 42%
• Positive Predictive Value 28%
• Elevated C-reactive Protein 28%
• High Risk 14%
• Blood Samples 14%
• After Surgery 14%
• Cox Model 14%
• Relapse Risk 14%
• 5-fluorouracil (5-FU) 14%
• Bootstrap 14%
• Fluoropyrimidine-based Chemotherapy 14%
• Kaplan-Meier 14%
• Disease-free 14%
• Patient Guidelines 14%
• Prognostic Information 14%
• Value-free 14%

Biochemistry, Genetics and Molecular Biology

• C-Reactive Protein 100%
• Interleukin 6 100%
• Carcinoembryonic Antigen 100%
• CA19-9 100%
• Overall Survival 27%
• Fluorouracil 18%

Immunology and Microbiology

• C-Reactive Protein 100%
• Carcinoembryonic Antigen 100%
• Interleukin 6 100%
• Colorectal Carcinoma 100%
• Overall Survival 27%